Our findings in a large, population-based registry of over 20 000 patients with a recent hospitalization for documented HF suggest that prescription of a non-selective beta-blocker is associated with ...

The appropriate duration of beta-blocker treatment after a heart attack (a myocardial infarction [MI]) is unknown in patients who do not need to take beta-blockers for another reason. In the ABYSS ...

Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...

A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said a researcher at the European Society of Cardiology (ESC) Congress, held ...

Learn how beta-blockers, including carvedilol, can be used in advanced liver disease to manage portal hypertension and reduce first decompensation risk.

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

Please provide your email address to receive an email when new articles are posted on . Optimal duration of beta-blockers after a heart attack remains unknown. The ABYSS trial provides new insights on ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Beta-blocker use did not reduce risk for death or new MI ...

A new class of beta blockers designed to activate only when struck by specific wavelengths of light could allow doctors to ...

Credit: Getty Images A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. Beta blockers have long been included in the ...